Hemoccult ICT is an immunochemical FOBT (iFOBT or FIT). It is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non-invasive, Hemoccult ICT is very patient friendly, as there are no diet or drug restrictions for patients to follow while they are using it, which helps increase patient compliance.
Hemoccult ICT Features:
- Hemoccult ICT is the most clinically proven fecal immunochemical test with high sensitivity and specificity(1). Fecal immunochemical tests, like Hemoccult ICT, are part of the standard of care for colorectal cancer screening.(2)
- Detects lower GI bleeding
- No dietary or drug restrictions
- 14-day on-slide sample stability
- 3-day and 2-day patient Collection Kits
- Available in boxes of 100 individual Collection Cards to meet ACS screening requirements
- Separate Collection Cards and Test Casettes minimize the financial risk of patients not returning Collection Cards
- Comprehensive patient educational support
- CLIA Category
- Waived
References:
1. Data on file, Beckman Coulter, Inc., Hemoccult ICT Product Instructions 2011
2. Smith RA, Cokkinides V, Eyre HJ.: “American Cancer Society Guidelines for the Early Detection of Cancer, 2003.” CA Cancer J Clin 2003;53:27-43
Product Overview
